PharmaFocus Today – Page 403 – media

Roche teams up with Lilly to validate Alzheimer’s blood test

March 22 (Reuters) – Roche (ROG.S) and Eli Lilly and Co (LLY.N) are joining forces to develop a blood test for Alzheimer’s disease, and plan to kick off a two-year clinical trial involving hundreds of volunteers with the aim of winning U.S. regulatory approval. The effort, unveiled in a statement on Wednesday, comes as Lilly as well as Eisai (4523.T) and Biogen (BIIB.O) are gearing up to sell drugs aimed at slowing the advance of the mind-robbing illness, but their use will require a diagnosis at earlier disease stages than is the norm today. Roche Holding AG would recruit several hundred volunteers with early signs of dementia over the next 18 to 24 months with trial data potentially ready for a U.S. regulatory filing in 2025, Bruce Jordan, leader of Personalized Healthcare Solutions at Roche Diagnostics, told Reuters. The U.S. Food and Drug Administration has asked Roche to recruit a significant number of patients at primary care facilities ...
- Source: drugdu
- 150
- March 22, 2023
All hormonal contraceptives ‘carry small increased risk of breast cancer’

Research finds use of progestogen is associated with a 20-30% higher risk but this falls after no longer taking it All types of hormonal contraceptives carry a small increased risk of breast cancer, according to research establishing a link with progestogen pills for the first time. The use of progestogen is associated with a 20-30% higher risk of breast cancer, data analysis by University of Oxford researchers has established. This builds on previous work showing that use of the combined contraceptive pill, which contains oestrogen and progestogen, is associated with a small increase in the risk of developing breast cancer that declines after stopping taking it. Claire Knight of Cancer Research UK, which funded the study, said the risk was small and should not discourage most people from taking the pill. She said: “Women who are most likely to be using contraception are under the age of 50, where the risk of ...
- Source: drugdu
- 126
- March 22, 2023
Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study

Pfizer and Astellas have reported positive top line results from a phase 3 trial of their androgen receptor signalling inhibitor, Xtandi (enzalutamide), in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical recurrence (BCR). The medicine is already a standard of care in the US for metastatic hormone-sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC), and for one or more of these indications in more than 100 countries. Compared with those indications, nmHSPC represents an earlier stage of disease, in which there is no detectable evidence of the cancer spreading to distant parts of the body, and it still responds to testosterone-lowering treatments. However, some patients remain at a higher risk for BCR following primary treatment, which may result in metastases. The EMBARK trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in metastasis-free survival (MFS) for patients treated daily ...
- Source: drugdu
- 157
- March 21, 2023
Sanofi to cut US insulin prices by up to 78% in January 2024

Sanofi has said it will cut the US list price of its most widely prescribed insulin by 78%, following similar moves by Novo Nordisk and Eli Lilly earlier this month. The changes will come into effect in January 2024 and will also include a $35 price cap on the same insulin, Lantus (insulin glargine injection), for those with commercial insurance. Around 8.4 million of the 37 million people in the US with diabetes use insulin, but the rising cost of the lifesaving medicine has been a pressing concern for many patients. Sanofi, Novo Nordisk and Eli Lilly produce over 90% of the US insulin supply and have come under recent fire over the rising costs of their products. In January, California attorney general Rob Bonta filed a lawsuit against the three drugmakers and leading pharmacy benefit managers for allegedly using their market power to overcharge patients for insulin. Other states ...
- Source: drugdu
- 146
- March 21, 2023
$2.9bn IMF bailout for struggling economy

Sri Lanka has secured a $2.9bn (£2.3bn) bailout from the International Monetary Fund (IMF) as it faces its worst economic crisis since independence. The deal has been nearly a year in the making and a lifeline for the country that has billions of dollars in loans. Foreign minister Ali Sabry told the BBC the government will raise funds by restructuring state-owned enterprises and privatising the national airline. However, analysts warned Sri Lanka still faces a tough road ahead. The country’s economy has been hit hard by the pandemic, rising energy prices, populist tax cuts and inflation of more than 50%. A shortage of medicines, fuel and other essentials also helped to push the cost of living to record highs, triggering nationwide protests which overthrew the ruling government in 2022. As a result the country defaulted on its debts with international lenders last May for ...
- Source: drugdu
- 136
- March 21, 2023
Excess Calories During Development Cause Overeating In Adulthood, Study Finds

Unhealthy food cravings in adulthood can be traced all the way back to fetal development, according to new research from Rutgers University. The study, published this week in Molecular Metabolism, shows that exposure to excess calories while in the womb can alter one’s brain and spur adult overeating. The researchers made the connection by studying 6 pregnant mice, then their combined litters of nearly 50 mice pups through adulthood. They began by letting 3 mice become obese on unlimited high-fat foods during pregnancy and breastfeeding, while keeping the other 3 pregnant mice slim from a diet of healthy food. The team found that the mice pups born to the obese mothers overate more than the mice pups born to the lean mothers when given access to unhealthy chow. The findings suggest that children who are born to mothers who were overweight during pregnancy and nursing may similarly struggle later in life to moderate ...
- Source: drugdu
- 149
- March 21, 2023
Fate of 1,000 trafficked lab monkeys at center of US investigation in limbo

‘Long-tailed macaques at risk of being killed, or laundered or re-trafficked if returned to Cambodia, animal welfare groups say’ More than a thousand Cambodian monkeys at the center of a US government investigation into wildlife trafficking are at risk of being killed or returned to their country of origin, laundered and re-trafficked, animal welfare groups say. The monkeys’ plight first came to light last year when the US Fish and Wildlife Service (FWS) asked the animal rights organization Peta about finding a sanctuary for 360 monkeys. Born Free USA, and the US Department of Justice (DoJ) later joined the discussions and the number of monkeys increased to over 1,000 as talks progressed. Last week, however, discussions stalled when Peta learned on 13 March that the monkeys would instead be flown out of the US. Under US law the monkeys can only return to their country of origin, Cambodia, said Dr Lisa Jones-Engel of Peta, ...
- Source: drugdu
- 188
- March 21, 2023
New Drug Combination Shows Promise in Treating Lung Cancer

Researchers from the University of Texas MD Anderson Cancer Center have found that a combination of two drugs may be effective in treating non-small cell lung cancer (NSCLC). NSCLC is the most common type of lung cancer and accounts for approximately 85% of all lung cancer cases. The study, published in the journal Nature Medicine, involved analyzing data from over 1,000 patients with NSCLC. The researchers identified a group of genes that were associated with resistance to immunotherapy, a type of cancer treatment that uses the body’s immune system to fight cancer cells. The researchers then tested a combination of two drugs, a checkpoint inhibitor and a targeted therapy, in mouse models of NSCLC. The checkpoint inhibitor works by releasing the brakes on the immune system, allowing it to attack cancer cells. The targeted therapy works by inhibiting a protein that is overexpressed in many types of cancer ...
- Source: drugdu
- 130
- March 21, 2023
Virtual Reality Therapy Shows Promise in Treating PTSD

A new study has found that virtual reality therapy may be an effective treatment for post-traumatic stress disorder (PTSD). PTSD is a mental health condition that can develop after experiencing or witnessing a traumatic event, such as military combat, sexual assault, or a natural disaster. Symptoms of PTSD can include flashbacks, nightmares, and anxiety. The study, published in The Lancet Psychiatry, involved 103 military veterans with PTSD. The veterans were randomly assigned to receive either virtual reality therapy or traditional therapy, which involved talk therapy and other forms of therapy. The virtual reality therapy involved wearing a headset that displayed virtual environments related to the veterans’ traumatic experiences. The veterans were able to interact with the virtual environments and practice coping strategies to manage their symptoms. The researchers found that the veterans who received virtual reality therapy had greater reductions in PTSD symptoms than those who received ...
- Source: drugdu
- 135
- March 21, 2023
Gene Editing May Hold the Key to Curing Sickle Cell Disease

Researchers from the University of California, Berkeley have used CRISPR gene-editing technology to cure sickle cell disease in mice. Sickle cell disease is a genetic blood disorder that affects millions of people worldwide. The disease is caused by a mutation in the HBB gene, which produces an abnormal form of hemoglobin that causes red blood cells to become misshapen and break down easily. Using CRISPR, the researchers were able to correct the HBB gene in mice with sickle cell disease. The corrected gene produced normal hemoglobin, which prevented the misshapen red blood cells from forming. The mice were cured of the disease and showed no signs of sickle cell-related symptoms. The researchers say that the same approach could be used to cure sickle cell disease in humans. While more research is needed before clinical trials can begin, this is a promising development in the field of gene therapy. ...
- Source: drugdu
- 137
- March 21, 2023

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.